D.E. Shaw & Co’s Medivation MDVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
– Sell
-60,000
Closed -$2.9M – 4121
2015
Q4
$2.9M Sell
60,000
-20,000
-25% -$863K ﹤0.01% 1843
2015
Q3
$3.4M Buy
80,000
+20,000
+33% +$991K 0.01% 1681
2015
Q2
$3.43M Hold
60,000
– – 0.01% 1772
2015
Q1
$3.87M Sell
60,000
-20,000
-25% -$1.15M 0.01% 1546
2014
Q4
$3.98M Hold
80,000
– – 0.01% 1738
2014
Q3
$3.96M Hold
80,000
– – 0.01% 1724
2014
Q2
$3.08M Hold
80,000
– – ﹤0.01% 1967
2014
Q1
$2.58M Buy
80,000
+71,200
+809% +$2.63M ﹤0.01% 2135
2013
Q4
$281K Hold
8,800
– – ﹤0.01% 4092
2013
Q3
$264K Hold
8,800
– – ﹤0.01% 3956
2013
Q2
$216K Buy
+8,800
New +$221K ﹤0.01% 3727

Other funds holding MDVN

D.E. Shaw & Co's MDVN Position: Q3 2016 in Review

D.E. Shaw & Co sold out of Medivation (MDVN) in Q3 2016, closing a stake of 759,256 shares — an estimated $45.8M sold.

D.E. Shaw & Co first reported a position in MDVN in Q2 2013 and held it in 13 quarters. The position peaked at $126M in Q3 2014. 53 funds tracked by Wall St. Rank hold MDVN as of Q3 2016.

  • D.E. Shaw & Co reported no remaining Medivation position as of Q3 2016 after selling out during the quarter.
  • D.E. Shaw & Co sold 759,256 Medivation shares in Q3 2016, an estimated $45.8M.
  • D.E. Shaw & Co first reported a position in Medivation in Q2 2013 and held it in 13 quarters.
  • D.E. Shaw & Co's Medivation position peaked at $126M in Q3 2014.
  • 53 funds tracked by Wall St. Rank held Medivation as of Q3 2016.

Based on D.E. Shaw & Co's 13F filing for Q3 2016, filed 14 Nov 2016.